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Homology and enzymatic requirements of
microhomology-dependent alternative end joining
S Sharma1, SM Javadekar1, M Pandey1, M Srivastava1, R Kumari1 and SC Raghavan*,1
Nonhomologous DNA end joining (NHEJ) is one of the major double-strand break (DSB) repair pathways in higher eukaryotes.
Recently, it has been shown that alternative NHEJ (A-NHEJ) occurs in the absence of classical NHEJ and is implicated in
chromosomal translocations leading to cancer. In the present study, we have developed a novel biochemical assay system
utilizing DSBs flanked by varying lengths of microhomology to study microhomology-mediated alternative end joining (MMEJ).
We show that MMEJ can operate in normal cells, when microhomology is present, irrespective of occurrence of robust classical
NHEJ. Length of the microhomology determines the efficiency of MMEJ, 5 nt being obligatory. Using this biochemical approach,
we show that products obtained are due to MMEJ, which is dependent on MRE11, NBS1, LIGASE III, XRCC1, FEN1 and PARP1.
Thus, we define the enzymatic machinery and microhomology requirements of alternative NHEJ using a well-defined
biochemical system.
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DNA double-strand breaks (DSBs) are the most deleterious to
the genome among various lesions. Nonhomologous end
joining (NHEJ) is one of the major DSB repair pathways in
higher eukaryotes.1–3 In the absence of key NHEJ factors,
another distinct but error-prone pathway known as alternative
NHEJ (A-NHEJ) has been described to have an important role
in DSB repair.4–7 It has been shown that majority of A-NHEJ-
mediated repair of DSBs utilize distinct microhomology
regions, hence termed microhomology-mediated end joining
(MMEJ).4,8,9
A-NHEJ has been proposed as a possible cause for
chromosomal translocations. Studies have shown co-
amplification of c-MYC and IgH locus from pro-B lymphomas
in mice deficient for p53 and NHEJ.10 A reduced level of class
switch recombination (CSR) and increased number of
chromosomal rearrangements at IgH locus have been shown
in XRCC4- and LIGASE IV-deficient murine B cells.8 The
occurrence of robust alternative end joining has been reported
in the absence of NHEJ proteins, when murine RAG proteins
were absent.11
Unraveling the enzymatic machinery involved in alternative
end joining is currently an active area of research. Recently, it
was shown that MRE11-RAD50-NBS1 complex may be
involved in a subset of alternative NHEJ,5,12–14 whereas
ATM has a regulatory role.15 Role of PARP1 in repairing switch
regions through a microhomology-mediated pathway leading
to IgH/c-MYC translocations during immunoglobulin CSR has
been described.16 Besides, studies have also suggested a
role for DNA LIGASE IIIα andWRN in A-NHEJ.17 Interestingly,
XRCC1 was shown to be dispensable in A-NHEJ during CSR,
whereas functional relevance of Ligase I, III and Pol λ have
been established.18–20 Hence, it can be concluded that
canonical NHEJ (C-NHEJ) requires LIGASE IV–XRCC4
complex, while A-NHEJ is predominant in the absence of
C-NHEJ proteins and is mainly characterized by joining
utilizing microhomology (MMEJ). Further, it has been demon-
strated that RPA, when bound to single-stranded DNA can
antagonize MMEJ.21 Very recently, a genetic system was
reported in budding yeast to detect microhomology-mediated
repair.22 However, little is known whether alternative NHEJ
can be operative when classical NHEJmachinery is intact.23 A
recent study suggested that MMEJ is also functional in normal
mammalian cells. Besides, HR and MMEJ share the initial
steps of end resection for DSB repair in mammalian cells.24
However, it appears that there is not much consensus among
different research groups over its presence and relevance in
normal cells.23 Therefore, several aspects of alternative NHEJ
still need to be resolved. For example, its precise mechanism
and microhomology length requirements are yet to be fully
uncovered. Its occurrence in normal cells needs to be proved
beyond doubt. Although there are independent studies
showing the role of multiple proteins using gene knockdown
or knockout strategies, their involvement needs to be
confirmed.
In the present study, we have established a cell-free repair
assay system using which we show that MMEJ is operative
even in the presence of classical NHEJ machinery. Further,
our data suggest that MMEJ operates not only in cancer cells
but also in normal cells. We show that a minimum of 5 nt
microhomology is required for MMEJ and is independent of
classical NHEJ proteins such as KU70, KU80 and LIGASE IV.
Finally, we show that MRN complex, XRCC1, FEN1, PARP1
and LIGASE III are the factors responsible for joining mediated
through microhomology.
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Results
A cell-free system to study backup NHEJ pathway.
Biochemical assay systems are used as ideal tools for
characterizing DNA repair pathways. In the present study,
we have used an in vitro approach utilizing a cell-free
system to biochemically characterize the mechanism of
microhomology-mediated alternative NHEJ.
The steps involved in assaying MMEJ are outlined
(Figure 1a). Two double-stranded oligomers of different
lengths, containing 10 (or 22) nt microhomology were
designed such that joining by utilizing microhomology results
in shortening of the product (62 or 76 nt), which can be
detected using radioactive PCR (Figures 1b and c). Similarly,
joining by C-NHEJ could result in reaction products of varying
sizes. In order to optimize assay conditions for MMEJ, various
parameters were tested. Increasing concentrations of rat
testicular extracts were incubated with DNA substrates
containing 10 nt microhomology for 2 h, heat inactivated,
PCR amplified using radiolabelled primers and resolved on
8% denaturing polyacrylamide gel. Results showed efficient
MMEJ (62 nt) from 200 ng protein onwards, whereas C-NHEJ
(~97 nt) was detectable only at protein concentration of 500 ng
onwards (Figure 2a). Time kinetics analysis showed MMEJ
and C-NHEJ from 5min onwards. Interestingly, kinetics of
C-NHEJ was faster compared with MMEJ (Figure 2b).
Besides, testicular extracts showed optimum MMEJ at 30 ºC,
the physiological temperature (Figure 2c). An enhancement in
the efficiency of MMEJ was observed with an increase in
concentrations of Mg2+, a co-factor, optimum being 10mM
(Figure 2d). Efficiency of MMEJ was maximum at 0.5 mM
adenosine triphosphate (ATP; Figure 2e). Sensitivity of MMEJ
assay was determined by serially diluting DNA and detecting
the joining from 100 pM onwards, which exponentially
increased till 4 nM (Supplementary Figure 1). Thus, we were
successful in establishing a cell-free repair assay system to
study MMEJ.
MMEJ in normal and cancer cells. In order to investigate
MMEJ in normal tissues, cell-free extracts were prepared
from rat testes and thymus and used for cell-free DSB repair
assay. Double-stranded DNA containing microhomology
were incubated in extracts (normal tissues and cancer cells,
for 2 h at 30 °C; Figures 3a–d). Results showed detectable
MMEJ in both normal tissues and cancer cell lines. MMEJ
was more prominent in testes compared with thymus among
normal tissues (Figures 3a–d). Upon comparing the relative
intensities of MMEJ products with input DNA substrates,
results indicated that 2–3% of DNA molecules would have
joined using microhomology in different cellular extracts
(Figure 3d). Besides MMEJ, we could detect joining
due to C-NHEJ despite using substrates that promote
microhomology-mediated joining (Figures 3c and d). Inter-
estingly, varying levels of MMEJ were observed in other
normal tissues such as spleen, lungs, heart, liver and kidney
(Supplementary Figure 2). Thus, our study revealed an
efficient MMEJ in normal tissues.
Figure 1 Schematic presentation of cell-free repair assay to evaluate microhomology-mediated alternative DNA end joining. (a) Outline of experimental strategy used for
detection of MMEJ. Two double-stranded oligomers possessing 10 nt microhomology were incubated with buffer and cell-free extracts. After heat inactivaction, end-joined
products were subjected to radioactive PCR and the products were resolved on 8% denaturing polyacrylamide gel. (b and c) Schematic showing strategy used for detection of
alternative NHEJ products using radiolabelled oligomers. Examples of 10 nt (b) and 22 nt (c) microhomology-bearing DNA substrates are depicted to show strategy employed for
detection of MMEJ. Dark rectangles indicate positions of microhomology. PCR primer positions are also indicated
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Cloning and sequencing of end-joined junctions from
independent biological repeats revealed that MMEJ could
take place in both normal and cancer cells by utilizing
microhomology (Figure 3e,Supplementary Figure 3). End-
joined junctions were also due to C-NHEJ, which was
characterized by small deletions or insertions (Figure 3e,
Supplementary Figure 3). These results confirmed the
occurrence of microhomology-mediated joining in normal
cells. Western blot analysis showed efficient expression of
RAD50, MRE11, ATM, PARP1, LIGASE IV and LIGASE III in
all four cell types (Figure 3f). Besides, we observed varying
expression of APLF, BRCA1, WRN and LIGASE I in normal
and cancer cells (Figure 3f).
Role of microhomology in alternative end joining. In
order to understand the extent of microhomology required for
MMEJ, oligomeric DNA containing DSBs flanked by various
lengths of microhomology (3, 5, 8, 10, 13, 16, 19 or 22 nt)
were designed and synthesized in such a way that following
MMEJ a restriction enzyme site would be generated
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Figure 2 Evaluation of different experimental conditions for the development of a cell-free repair system to assess microhomology-mediated alternative DNA end joining.
(a) Evaluation of MMEJ in presence of increasing concentrations of cell-free extracts. Testicular extracts (0, 0.025, 0.050, 0.075, 0.1, 0.2, 0.5, 0.75, 1.0, 1.5, 2.0, 2.5 and 3.0 μg)
were incubated with DNA substrates (4 nM) 10 nt microhomology for 2 h at 30 °C. Lane 1 indicates no protein control. (b) Time kinetics of MMEJ on a 10-nt microhomology-
containing DNA substrates. Rat testicular extracts (1 μg) were incubated with DNA substrates for 0, 5, 15 and 30 min, and 1, 2, 4, 6, 8, 10 and 12 h, and products were analyzed
on 8% denaturing PAGE. (c) MMEJ assay at increasing incubation temperatures. A unit of 1.0 μg of extract was incubated with 10 nt microhomology-containing DNA substrates in
rat testicular extracts for 2 h at 4, 16, 25, 30, 37 and 40 °C. Lane 1 is no protein control. (d) Effect of MgCl2 on MMEJ catalyzed by cell-free extracts. Rat testicular extracts (1 μg)
were incubated with microhomology substrates and increasing concentrations of MgCl2 at 30 °C. Lane 1 is no protein control. Lanes 2–7 indicate MMEJ in the presence of 0, 1, 2,
5, 10 and 20 mM of MgCl2, respectively. (e) Effect of ATP on MMEJ catalyzed by cell-free extracts. Rat testicular extracts (1 μg) was incubated with microhomology substrates and
increasing concentrations of ATP for 2 h. Lanes 2–8 indicate MMEJ in the presence of 0, 0.1, 0.25, 0.5, 1, 2 and 4 mM of ATP, respectively. In panels a–e, bar diagram showing
quantification based on at least three independent experiments are provided. MMEJ products are indicated by an arrow, while C-NHEJ products are bracketed. In each case,
lower panel serves as the loading control for equal DNA, indicated as ‘input DNA’. Mʹ and M indicate 60 nt marker and 50 nt ladder, respectively. PSLU in y axis of bar diagram
indicates photostimulated luminescence units.*Po0.05; **Po0.01; ***Po0.001. Error bars represent S.E.M.
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(Figure 4a and Supplementary Tables 2 and 4A). Results
showed a prominent band due to MMEJ in all the substrates,
except for 3 nt microhomology, when incubated with testicular
extracts (Figure 4b). In order to corroborate this observation,
PCR products obtained from 3, 5, 8 and 13 nt microhomology
substrates following MMEJ reaction, were digested with NotI,
XmnI and XcmI, respectively. A low-intensity band corre-
sponding to ~ 55 nt in 5 nt microhomology substrate was
detected, which was digestible with NotI indicating that the
joining was mediated by MMEJ (Supplementary Figure 4b).
Similarly, bands corresponding to ~ 60 and 65 nt in 8 and 13
nt microhomology substrates were digestible with XmnI and
XcmI, respectively (Supplementary Figure 4b). Besides, we
could not find any specific band, which was sensitive to NotI
digestion when 3 nt microhomology substrate was used
(Supplementary Figure 4b). As there was no suitable
restriction enzyme site, we could not perform similar analysis
for substrates containing 10 nt microhomology. These
findings suggest that MMEJ protein machinery recognizes
microhomology regions to undergo end joining. Furthermore,
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Figure 3 Comparison of frequency and mechanism of MMEJ between normal and cancer cells. (a) SDS-PAGE profile of cell-free extracts prepared from testis, thymus, K562
and Reh. (b) Bar diagram showing densitometry analysis for proteins in PAGE shown in panel a. (c) Comparison of MMEJ and C-NHEJ efficiency catalyzed by testis, thymus,
K562 and Reh cell-free extracts. Cell-free extracts (1.0 μg) were incubated with oligomeric DNA possessing 10 nt microhomology in a buffer containing 10 mM Tris⋅HCl (pH 8.0),
20 mMMgCl2, 1 mM ATP, 10% PEG 8000 and 1 mM DTT for 2 h at 30 °C. The products were resolved on a PAGE and visualized. For other details refer Figure 2 legend. M is 50 nt
ladder. M is marker for 60 nt position. MMEJ and NHEJ products are indicated. (d) Bar diagram showing comparison of MMEJ and C-NHEJ catalyzed by testis, thymus, K562 and
Reh, relative to input. *Po0.05. Error bars represent S.E.M. (e) Comparison of different modes of NHEJ among normal tissues and cancer cell lines. The total end-joining
junctions from testis, thymus, K562 and Reh cells were PCR amplified, cloned and sequenced. Each sequence shown is derived from an independent clone. Cases where
microhomology is used are indicated in the column. The ‘joined products’ indicate the usage of substrates. Red color indicates sequences that are deleted, while blue indicates
insertions. Green indicates mutations in the sequence. Microhomology region is underlined and the sequence is indicated in bold. (f) Western blots showing expression profile of
canonical and noncanonical NHEJ proteins in testes, thymus and leukemic cell lines. Bands marked with an asterisk could be an isoform. Both isoforms of Ligase III, α and β, are
indicated. PCNA and actin were used as loading control
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a microhomology length of more than 3 nt is essential for its
operation.
Comparison of MMEJ in thymic cell-free extracts showed an
increase in the efficiency of joining with an increase in length of
microhomology (data not shown). Similar to testicular extracts,
we could not detect any joining due to MMEJ, in case of
3 nt microhomology-containing DNA substrates. MMEJ
was observed in K562 and Reh cell-free extracts, when
substrate containing as low as 5 nt microhomology was used
(Figure 4c and data not shown). Further, a definitive
enhancement in the MMEJ efficiency was observed with an
increase in length of microhomology, which was consistent
with the results seen in budding yeast.22 In all cases, reaction
products due to joining through NHEJ were also seen
(Figure 4c).
In order to confirm the identity of potential MMEJ products,
corresponding bands were excised, purified and subjected to
DNA sequencing for 3, 5, 8, 10, 13 and 16 nt microhomology-
containing substrates. Results confirmed the presence of
MMEJ in case of each substrate, when the microhomology
was 8 nt or more (Figure 5a). In case of 5 nt microhomology
substrates, only few junctions utilized microhomology (based
on restriction digestion analysis), whereas majority of the
joining was through C-NHEJ. In case of 3 nt microhomology
substrates, none of the clones showed usage of microhomol-
ogy. Unlike C-NHEJ, MMEJ junctions did not show any
insertions, although point mutations were rarely seen. Similar
results were also seen whenMMEJ junctionswere sequenced
from thymus (Figure 5b). These results suggest that theMMEJ
is dependent on the length of microhomology region.
MMEJ is not dependent on classical NHEJ proteins. As
we could distinguish MMEJ products using cell-free repair
system, we were interested in protein machinery responsible
for alternative NHEJ. To begin with, possible involvement of
C-NHEJ proteins like KU70, KU80 and LIGASE IV was tested
by immunoprecipitation (IP) (Figure 6a) followed by joining
assay. No effect on MMEJ products (10 or 19 nt micro-
homology) was observed when immunodepleted extracts of
KU70, KU80 and LIGASE IV were used (Figure 6b).
However, a significant decrease in the efficiency of C-NHEJ
products was observed. Further, we could find an
overall decrease in the efficiency of joining when 3 nt
microhomology-containing substrate was used (Figure 6b).
Consistent with these findings, when cell-free extracts were
prepared from LIGASE IV knockout cells, there was no
reduction in MMEJ efficiency, whereas C-NHEJ was sig-
nificantly inhibited (Figure 6c). Besides, immunodepletion of
POL μ or POL λ also did not result in any significant reduction
in the efficiency of MMEJ, whereas levels of NHEJ products
were substantially reduced (Figure 6d).
Wortmannin, an inhibitor of DNA-PKcs, is known to block
NHEJ in its initial stages.25 Testicular extracts were incubated
with increasing concentrations of wortmannin (1, 10 and
100 μM) and tested for its effect on MMEJ by using 10 and 19
nt microhomology substrates (Figure 6e,Supplementary
Figure 5). Results showed a reduction in NHEJ products upon
an increase in concentrations of wortmannin in case of 10 nt
microhomology substrates, whereas the efficiency of MMEJ
remained unaltered (Figure 6e). However, at highest concen-
tration of wortmannin, a minor reduction in MMEJ was
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observed, which could be attributed to the ability of wortman-
nin to inhibit other PI 3-kinases (Figure 6e).26 Inhibition of
C-NHEJ along with an increase in MMEJ could be observed
with 19 nt microhomology substrate upon treatment with
wortmannin (Supplementary Figure 5). Thus, this result, in
conjunction with above findings, suggests that MMEJ is not
dependent on classical NHEJ proteins.
In order to test whether the results obtained using the cell-
free repair system are relevant at the cellular level, siRNA-
mediated knockdown of C-NHEJ proteins was performed.
siRNA against KU70, KU80, XRCC4 or LIGASE IV were
transfected in Reh cells and cell-free extracts were prepared
along with scrambled siRNA control. Knockdown of respective
protein was confirmed by western blotting (Figure 6f). When
these cell-free extracts were used for MMEJ assay on
substrates with DSBs flanked with 3, 10 and 19 nt micro-
homology, an overall reduction in the efficiency of joining of 3
nt microhomology substrate was observed (Figure 6g). In
contrast, substrates possessing 10 and 19 nt microhomology,
showed improved efficiency of MMEJ upon knockdown of
KU70, KU80, XRCC4 or LIGASE IV (Figure 6g). As expected,
C-NHEJ products exhibited a remarkably low efficiency of
joining (Figure 6g). Hence, siRNA knockdown within the cells
in conjunction with immunodepletion studies suggest that
C-NHEJ proteins are not involved during MMEJ.
Microhomology-mediated alternative NHEJ is dependent
on other repair proteins. As MMEJ is independent of
C-NHEJ proteins, we were interested in identifying the
proteins involved in MMEJ. On the basis of previous studies,
we selected candidate protein targets for the study. Immu-
nodepletion of XRCC1, PARP1 and LIGASE I was performed
from rat testicular extracts (Figure 7a) and used for MMEJ on
a 10-nt microhomology substrate. Interestingly, results
showed a significant decrease in the efficiency of MMEJ,
whereas C-NHEJ remained same in case of XRCC1-,
LIGASE I- and PARP1-immunodepleted extracts as com-
pared with that of control (Figure 7b). This suggests that
MMEJ utilizes protein machinery consisting of XRCC1,
LIGASE I and PARP1.
Figure 5 Sequence analysis of MMEJ junctions, when DSBs with different microhomology regions were used. Products due to possible MMEJ (3, 5, 8, 10, 13 and 16 nt
microhomology) catalyzed by testicular and thymic extracts were gel purified, cloned and sequenced. The sequences denoted in red color are the deleted nucleotides. (a) MMEJ
junctions from rat testicular extracts. (b) MMEJ junctions derived from rat thymic extracts. For other details, refer Figures 1 and 4 legends
Characterization of microhomology-mediated end joining
S Sharma et al
6
Cell Death and Disease
Mirin inhibits MRE11, an enzyme involved in homologous
recombination and suggested to have a potential role in A-
NHEJ.27 Testicular extracts were incubated with increasing
concentrations of mirin (100, 200, 400, 600, 800 and 1000 μM)
and used for MMEJ reaction with 3, 10 and 19 nt micro-
homology substrates. Results showed reduction in the
formation of MMEJ products with increasing concentrations
of mirin, whereas its effect on NHEJ was minimal (Figure 7c),
except at higher concentrations, which could be attributed to
nonspecificity. These results indicate the possible involvement
of MRN complex in MMEJ.
siRNA-mediated knockdown was performed in Reh cells to
evaluate the role of MRE11, RAD50, NBS1, PARP1, FEN1,
ARTEMIS and LIGASE III in MMEJ in physiological context.
Cell-free extracts were prepared from experimental and
scrambled siRNA-treated cells. Following confirmation of the
knockdown by western blotting (Figure 7d), MMEJ assay was
carried out on substrates harboring 3, 10 or 19 nt micro-
homology. Results showed a distinct reduction in MMEJ when
MRE11, NBS1, LIGASE III, PARP1 expressionswere knocked
down in case of substrates possessing 10 and 19 nt
microhomology (Figure 7e). Interestingly, inhibition of RAD50
expression did not result in significant reduction in MMEJ in
case of 10 nt microhomology-containing substrate (Figure 7e).
However, we did not observe any significant difference in the
efficiency of C-NHEJ products upon knockdown of these
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genes (Figure 7e). Consistent with previous results, there was
no significant reduction in the efficiency of joining of 3 nt
microhomology substrate (Figure 7e). Results showed a
reduction in MMEJ, when FEN1 was knocked down, whereas
ARTEMIS knockdown did not showany significant reduction in
MMEJ (Supplementary Figure 6). As expected, ARTEMIS
knockdown resulted in lower C-NHEJ, whereas FEN1 did not
affect its efficiency (Supplementary Figure 6). Hence, our
results suggest that MRE11, NBS1, PARP1, XRCC1, FEN1,
LIGASE I and LIGASE III are essential for microhomology-
mediated joining.
Discussion
DSBs generated either physiologically or pathologically need
to be repaired to maintain the integrity of genome in order to
ensure the survival of a cell.3 Multiple NHEJ pathways have
been proposed for repairing various types of DSBs. Recently,
a DNA-PK- and/or KU-independent alternative pathway has
been suggested to repair DSBs using microhomology,
and to be responsible for deletions and chromosomal
translocations.4,28,29 Microhomology-mediated joining is a
major form of alternative NHEJ and has been suggested to
operate in cells that are deficient in C-NHEJ.6 MMEJ is utilized
when C-NHEJ is compromised; however, the extent of its
activity in normal physiological conditions is a question yet to
be resolved.23,28,30
MMEJ is dependent on microhomology and occurs in
normal cells. In the present study, we have established a
biochemical system to study MMEJ. By using such a system,
we are able to detect MMEJ even in normal cells, when
microhomology regions are provided. More importantly, this
assay system helps in distinguishing joining mediated by both
MMEJ and C-NHEJ simultaneously. This suggests that
although classical NHEJ is normally predominant, MMEJ
can occur in both normal and cancer cells, when DSBs flank
the microhomology regions.
Previously, we have shown that efficiency and mode of DSB
joining is dependent on DNA end configurations.31 In the
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present study, whenDNApossessing different microhomology
(3–22 nt) were used, a length of 3 nt microhomology was
insufficient to recruit MMEJ machinery; instead C-NHEJ was
preferred. Importantly, a 5-nt microhomology was sufficient to
elicit MMEJ consistent with the earlier results.22 However,
MMEJ efficiency was improved when longer microhomology
was present. Class switch recombination occurs at 20–50% of
the stimulated cells and several joining junctions use longer
microhomology in C-NHEJ-deficient B cells.8 Preferential
joining using 7 nt microhomology was reported in KU80- and
XRCC4-deficient cells.32 Therefore, length of microhomology
is one of the factors that determine the recruitment of the
protein machinery for MMEJ. Previously, plasmid-based
biochemical assay systems were used to study backup NHEJ
pathways using cell lines deficient for DSB repair
proteins.33–35
MMEJ utilizes specific protein machinery and can coexist
along with C-NHEJ. Our results showed that in physiologi-
cal scenario, the set of proteins required for C-NHEJ and
MMEJ are distinct. Specifically, during MMEJ, following the
end resection, microhomology regions are aligned in such a
way that intact product formation takes place following
processing of the flap region and ligation. On the basis of
our studies, it appears that the efficiency of joining by MMEJ
is particularly more favorable when the substrates possess
ends with microhomology, hence exhibiting lower efficiency
by C-NHEJ.31 Besides, based on the studies from our group
and others, it appears that there is a complete set of proteins
that can perform MMEJ.5,6,8,9,11,18,19,36 In the physiological
context, when some of the ends are left unrepaired, it is
possible that this repair machinery takes over the process to
repair such DNA ends. However, other than microhomology,
the additional factors contributing toward the selection of
such alternative pathway, within cells, are yet to be under-
stood. Mutation in one of the C-NHEJ proteins alone may not
be solely responsible. Recently, MMEJ has been described
as the repair mechanism involved in generation of chromo-
somal translocations.8 The fact that many such rearrange-
ments are reported in remarkably higher frequency in healthy
individuals further confirm that alternative pathway of NHEJ
might be operating in normal scenario as well.37–42 It is well
known that the first hit of genetic alterations like chromosomal
translocations and deletions, which lead to carcinogenesis,
occur in noncancerous cells. Thus, our observations of
MMEJ in normal cells are of great importance.
Microhomology-mediated alternative NHEJ is dependent
on MRE11, NBS1, PARP1 and LIGASE IIIα/XRCC1 com-
plex. By using both immunodepletion along with inhibitor
studies in cell-free extracts and siRNA-mediated knockdown
within the cells, we deciphered that classical NHEJ proteins
are not required for microhomology-mediated alternative
NHEJ (Figure 8). Instead, we found that proteins such as
PARP1, XRCC1, LIGASE III, MRE11, FEN1 and NBS1 are
important for MMEJ (Figure 8). As MRN complex has an end
resection property, it searches for homology and once
aligned, DSBs are joined using LIGASE III/XRCC1.43
Alternatively, it is possible that a yet unidentified protein
recognizes the microhomology region and recruits MRN
complex or PARP proteins to the site of repair. Role of
MRE11 in alternative NHEJ has been shown earlier.9 Here
we observed a significant reduction in the intensity of MMEJ
product and a slight reduction in C-NHEJ products upon
removal of MRN complex in case of substrates containing
either 10 or 19 nt microhomology. Earlier studies have shown
that depletion or inhibition of MRE11 reduces end joining in
wild-type and XRCC4− /− cells showing that MRE11 pro-
motes both C-NHEJ and MMEJ.13,14 Studies have also
shown the potential role of PARP1 and DNA LIGASE III in
alternative pathway of NHEJ using in vivo plasmid rejoining
assay.34 DNA LIGASE III as a candidate component of
backup end joining was suggested by fractionation studies
using plasmid rejoining assay.35 Further, it has been shown
that involvement of XRCC1–LIGASE III was independent of
DNA-PK and XRCC4–LIGASE IV.44
Hence, our study establishes a well-defined biochemical
system for the characterization of microhomology-mediated
alternative NHEJ. It opens a new window to understand the
relative frequency of classical NHEJ and MMEJ under
physiological conditions. It might also help to interpret the
physiological conditions where one pathway may be chosen
over the other while repairing DNA DSBs, which could further
help in understanding the generation of chromosomal
translocations leading to cancer.
Materials and Methods
Enzymes, chemicals and reagents. Chemical reagents were obtained
from Sigma Chemical Co. (St Louis, MO, USA), Amresco (Solon, OH, USA), SRL
(Mumbai, India) and Himedia (Mumbai, India). DNA-modifying enzymes were from
New England Biolabs (Beverly, MA, USA) and antibodies were purchased from
Santa Cruz Biotechnology (Dallas, TX, USA). Radioisotope-labelled nucleotides
were purchased from BRIT (Hyderabad, India).
Preparation of DNA substrates for MMEJ. Oligomers containing
appropriate microhomology regions were designed and commercially synthesized
(Supplementary Table 1). The oligomers were then purified on denaturing
polyacrylamide gels as described.45 In order to generate double-stranded
oligomeric DNA containing DSBs with flanking microhomology regions, comple-
mentary oligomers were annealed in 100 mM NaCl and 1 mM EDTA, as
described.31 Length of microhomology region used in the study is 3, 5, 8, 10,
13, 16, 19 and 22 nt (Supplementary Table 2). The 5′ end-labelling ((γ-32P) ATP) of
the SS60 and other oligomers was done using T4 polynucleotide kinase as
described previously46 and stored at − 20 oC.
Preparation of cell-free extracts from tissues and cell lines. Cell-
free extracts were prepared from testes and thymus of male winstar rats (3–
4 weeks), as described earlier.31,47 Extracts were aliquoted and stored at − 80 °C till
use. Protein concentration was determined by Bradford’s assay. Protein amount was
normalized further by loading on SDS polyacrylamide gel, followed by staining with
Coomassie Brilliant Blue.
Cell-free extracts from cell lines K562 (human immortalized myelogenous
leukemia line) and Reh (acute lymphocytic leukemia line) were prepared as
described.25 Briefly, cells were washed with PBS followed by washing in hypotonic
lysis buffer (10 mM Tris⋅HCl (pH 8.0), 1 mM EDTA and 5 mM DTT). Cells were
resuspended in 100 μl of hypotonic buffer followed by homogenization after 20 min,
and protease inhibitors were added (phenylmethylsulfonyl fluoride, 0.01 M; aprotinin,
2 μg/ml; pepstatin, 1 μg/ml; leupeptin, 1 μg/ml). After 20 min on ice, 50 μl of high-salt
buffer (50 mM Tris⋅HCl (pH 7.5), 1 M KCl, 2 mM EDTA and 2 mM DTT) was added,
and the extract was centrifuged for 3 h at 42 000 r.p.m. at 4 °C in a Beckman TLA-100
Rotor (Beckman, Palo Alto, CA, USA). The supernatant was dialyzed overnight
against dialysis buffer (20 mM Tris⋅HCl (pH 8.0), 0.1 M KOAc, 20% glycerol, 0.5 mM
EDTA and 1 mM DTT), snap frozen and stored at − 80 °C.
Characterization of microhomology-mediated end joining
S Sharma et al
9
Cell Death and Disease
Evaluation of MMEJ. DNA end joining assay was performed by incubating
4 nM of radiolabelled oligomeric DNA containing microhomology in cell-free extracts
(1 μg), unless specified otherwise (testicular cells) in a buffer (10 mM Tris⋅HCl (pH
8.0), 20 mM MgCl2, 1 mM ATP, 10% PEG 8000 and 1 mM DTT) in a reaction volume
of 20 μl at 30 °C for 2 h or as specified (Figure 1a). End-joining reactions were
arrested by heat inactivation of proteins at 65 °C for 20 min. Products were detected
by PCR using (γ-32P) ATP-labelled primer, SS60 and unlabelled primer SS61
(denaturation: 95 °C for 3 min (1 cycle); denaturation: 95 °C for 30 s, annealing:
58 °C for 45 s, extension: 72 °C for 30 s (15 cycles); extension: 72 °C for 3 min
(1 cycle)). Reaction products were resolved on an 8% denaturing polyacrylamide
gel, and signals were acquired using a PhosphorImager (GE, Pittsburgh, PA, USA).
The quantity of input DNA in the PCR reaction was determined by the amplification
of the longer MMEJ substrates using primers (MS143 and MS144), which served as
the control. Each experiment described in the present study was performed a
minimum of three independent times. Results were in good agreement and
representative gels with quantifications are shown.
Cloning and sequencing of end-joined junctions. For cloning of total
reaction products, PCR was performed using primers SS60 and SS61. For cloning
of prospective MMEJ products, the band of interest was excised and purified from
the gel and used for PCR amplification using same set of primers. In all cases, PCR
products were purified and cloned into TA vector as described.48 The presence of
insert was confirmed by restriction enzyme digestion followed by DNA sequencing
(SciGenom Labs Pvt Ltd., Cochin, India).
siRNA transfection. Reh cells were used for siRNA transfection studies.
Briefly, Reh cells (2.5 × 106) were transfected with a cocktail of siRNA against KU70,
KU80, XRCC4, LIGASE IV, MRE11, RAD50, NBS1, PARP1 or LIGASE III using
oligofectamine as described earlier.49 The cells were harvested after 48 h and cell-
free extracts were prepared as described above. The efficiency of knockdown was
confirmed using immunoblotting and used for assessing DNA end joining.
Immunoblotting and IP. For immunoblotting analysis, 20–40 μg of protein
was resolved on 7–10% SDS polyacrylamide gel.49,50 Following electrophoresis,
proteins were transferred to PVDF membrane (Millipore, Billerica, MA, USA), and
probed with appropriate primary antibodies against KU70, KU80, XRCC4, LIGASE
IV, POL λ, POL μ, MRE11, WRN, CtIP, APLF, PARP1, BRCA1, RAD50, NBS1,
LIGASE I and LIGASE III (Santa Cruz Biotechnology) and appropriate secondary
antibodies as per standard protocol. TUBULIN, GAPDH, PCNA or ACTIN were
used as internal loading controls. The blots were developed using chemiluminescent
solution (Immobilon Western, Millipore) and scanned by gel documentation system
(LAS 3000, Fuji, Shizuoka, Japan).
IP experiments were performed independently for respective proteins as
described previously.31,51 Protein G agarose beads (Sigma, St. Louis, MO, USA)
were incubated with appropriate antibody (0.04 μg/μl) overnight in IPP buffer (0.5 M
NaCl, 10 mM Tris (pH 7.5) and 0.2% NP-40). The beads were spun down and the
supernatant was removed. A unit of 50 μg of rat testicular extract was then mixed
with the antibody-bound beads and incubated. The immunodepletion was
confirmed by western blot analysis. Images were quantified using Multi Gauge
(V3.0; Fujifilm, Tokyo, Japan) and presented as bar diagram. The immunodepleted
extract was then used for MMEJ assay.
Quantification. For quantification of bands of interest, Multi Gauge (V3.0)
software was used as described.31 A rectangle was selected covering the band of
interest and the intensity was quantified. A similar rectangle was then placed over
other bands of interest in each lane, quantified and added. An equal area from the
same lane of the blot where no specific band was present was used as background
and subtracted. The intensity obtained from each lane was plotted and presented as
bar diagram.
Recognition of DSBs dependent on microhomology
Recruitment of 
MRN complex proteins and PARP1
Recruitment of 
FEN1/endonucleases
Recruitment of 
XRCC1/Ligase III
? ?
Recruitment of KU70, 
KU80 and DNA-PKCs
Recognition of DSBs irrespective of microhomology
Processing of ends 
by Artemis
Pol μ and λ dependent synthesis and
recruitment of XRCC4/LIGASE IV
Ligation Ligation
Classical NHEJ Microhomology mediated NHEJ
Figure 8 Mechanism of microhomology-mediated alternative NHEJ. Schematic presentation shows different modes of DSB repair via NHEJ and MMEJ. When a DSB is
generated flanking a microhomology region, there are two outcomes. If KU proteins bind to the ends and recruit C-NHEJ proteins, it can result in C-NHEJ. Alternatively, if the
microhomology is recognized by MRN complex and PARP1 or a yet unidentified protein, it can follow MMEJ. This is followed by recruitment of FEN1/unknown endonucleases,
which can remove the flap. Further, recruitment of XRCC1–LIGASE III at the site helps in ligating the DNA ends leading to an intact DNA
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Statistical analyses. Values are expressed as mean± S.E.M. for control and
experimental samples, and statistical analyses were performed by one-way ANOVA
followed by unpaired Student’s t-test with GraphPad Prism 6 software (San Diego,
CA, USA). The values were considered statistically significant, if the P≤ 0.05.
DNA end-joining assay in presence of MRE11 and DNA-PKcs
inhibitors. Reaction with wortmannin (DNA-PKcs inhibitor) or mirin (MRE11
inhibitor) was carried out as described.25 Different concentrations of inhibitors were
incubated with protein extracts for 30 min on ice, shifted to 25 °C for 15 min, and
then 4 nM of substrate was added and incubated for 2 h. End-joined junctions were
then PCR amplified and loaded onto 8% denaturing polyacrylamide gel. The images
were acquired as described above.52,53
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